MDLZ Revenue Growth (YoY) Analysis
Updated 153h ago·SEC filings & market data
Key Takeaway
Revenue growth (YoY) of 8.2% means MDLZ’s current sales are 8.2% higher than in the same quarter last year, a basic measure of business expansion.
Sector Performance
47th percentileMDLZ
8.2%
Sector Median
9.0%
Sector Avg
14.8%
Deep Analysis
Revenue growth (YoY) of 8.2% means MDLZ’s current sales are 8.2% higher than in the same quarter last year, a basic measure of business expansion.
This sits just above the sector median of 7.8%, placing the company at the 51st percentile among peers—essentially mid-pack. Trend direction is unavailable: the year-over-year change is N/A and the quarter-over-quarter change is N/A, so no recent momentum can be assessed. With only a single data point slightly above the sector norm and no trend signal, the investment risk or opportunity is modest and undefined. This metric supports the overall NEUTRAL verdict, as the growth level is neither a standout strength nor a clear weakness.
Frequently Asked Questions
What does the Revenue Growth (YoY) tell investors about MDLZ?
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
How is the Revenue Growth (YoY) calculated?
Revenue Growth (YoY) is calculated as: (Revenue_t - Revenue_t-4) / Revenue_t-4.
Who are MDLZ's closest peers by Revenue Growth (YoY)?
The closest peers by Revenue Growth (YoY) include: TMUS (7.9%), MCK (7.7%), SIEGY (7.3%), CB (7.2%), MHK (6.8%).
Learn More About Revenue Growth (YoY)
The Formula
(Revenue_t - Revenue_t-4) / Revenue_t-4
Why It Matters
Year-over-year revenue acceleration is one of the strongest signals of business momentum. Sustained >15% growth is rare and typically re-rated by the market.
Master MDLZ's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MDLZ research report →MDLZ
8.2%
Sector Median
9.0%
Sector Avg
14.8%
How MDLZ's Revenue Growth (YoY) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.